Australia’s First Psychedelic Research Institute Opens with $40 Million Investment

Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.

Australia’s First Psychedelic Research Institute Psychae Opens with $40 Million Investment